Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Stromectol inactive ingredients?Goodrx premarin cream 0 625 mg g price?Zejula approval date?Ketorolac for arthritis?Ofloxacin price trend?
See the DrugPatentWatch profile for Voquezna
The generic name for Voquezna is amifampridine [1].
Amifampridine is used to treat Lambert-Eaton myasthenic syndrome (LEMS) in adults [1]. LEMS is a rare autoimmune disorder that affects the nerves and muscles [2].
Amifampridine works by blocking potassium channels in nerve cells. This action enhances the release of acetylcholine, a neurotransmitter that helps muscles contract [1]. By increasing acetylcholine levels at the neuromuscular junction, amifampridine can improve muscle strength and function in individuals with LEMS [2].
Information regarding specific patent expiry dates for amifampridine or its brand-name formulation, Voquezna, is not readily available in the provided context. DrugPatentWatch.com tracks patent information for pharmaceuticals [3].
While amifampridine is a treatment for LEMS, other approaches may be used. These can include immunosuppressive therapies aimed at reducing the autoimmune attack on the neuromuscular junction, alongside symptomatic treatments to manage muscle weakness [2].
Other Questions About Voquezna :